Texas Instruments (TXN) Market Value Rose While Marathon Asset Management Llp Has Lifted Holding by $8.07 Million; Novartis Ag Spnsrd Adr (NVS) Stock Value Rose While First Financial Cut by $692,801 Its Stake

November 15, 2017 - By Peter Erickson

Bruce J. Richards increased its stake in Texas Instruments Inc (TXN) by 10% based on its latest 2017Q2 regulatory filing with the SEC. Marathon Asset Management Llp bought 106,234 shares as the company’s stock rose 5.05% with the market. The hedge fund run by Bruce J. Richards held 1.17M shares of the semiconductors company at the end of 2017Q2, valued at $89.87 million, up from 1.06M at the end of the previous reported quarter. Marathon Asset Management Llp who had been investing in Texas Instruments Inc for a number of months, seems to be bullish on the $95.06 billion market cap company. The stock declined 0.53% or $0.51 reaching $96.45 on the news. About 101,856 shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 40.31% since November 15, 2016 and is uptrending. It has outperformed by 23.61% the S&P500.

First Financial Corp decreased its stake in Novartis Ag Spnsrd Adr (NVS) by 72.34% based on its latest 2017Q2 regulatory filing with the SEC. First Financial Corp sold 8,347 shares as the company’s stock rose 4.17% with the market. The institutional investor held 3,191 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $267,000, down from 11,538 at the end of the previous reported quarter. First Financial Corp who had been investing in Novartis Ag Spnsrd Adr for a number of months, seems to be less bullish one the $214.86 billion market cap company. The stock declined 0.37% or $0.31 reaching $82.72 per share. About 177,592 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 15, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.




Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on January, 24. They expect $1.16 EPS, up 3.57% or $0.04 from last year’s $1.12 per share. NVS’s profit will be $3.01 billion for 17.83 P/E if the $1.16 EPS becomes a reality. After $1.29 actual EPS reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts -10.08% negative EPS growth.

Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Tuesday, July 18 by Cowen & Co. The firm has “Buy” rating by Chardan Capital Markets given on Monday, October 10. Cowen & Co maintained Novartis AG (ADR) (NYSE:NVS) rating on Monday, July 10. Cowen & Co has “Hold” rating and $7700 target. The firm has “Buy” rating by Societe Generale given on Wednesday, March 8. The stock has “Sell” rating by Barclays Capital on Wednesday, October 25. The stock has “Hold” rating by Argus Research on Tuesday, April 5. The stock has “Neutral” rating by Credit Suisse on Wednesday, January 11. As per Thursday, March 23, the company rating was maintained by Goldman Sachs. The rating was downgraded by UBS to “Neutral” on Friday, April 1. The stock of Novartis AG (ADR) (NYSE:NVS) has “Hold” rating given on Friday, October 13 by Cowen & Co.

First Financial Corp, which manages about $157.46M US Long portfolio, upped its stake in Abbvie Inc (NYSE:ABBV) by 9,430 shares to 23,526 shares, valued at $1.71 million in 2017Q2, according to the filing.

Investors sentiment decreased to 1.1 in 2017 Q2. Its down 0.06, from 1.16 in 2017Q1. It turned negative, as 43 investors sold TXN shares while 349 reduced holdings. 106 funds opened positions while 324 raised stakes. 778.17 million shares or 5.60% less from 824.35 million shares in 2017Q1 were reported. Kornitzer Cap Mgmt Ks holds 10,150 shares or 0.01% of its portfolio. X Company Lc holds 0.02% or 6,416 shares. Ims Cap Management has invested 0.26% in Texas Instruments Incorporated (NASDAQ:TXN). Wms Ptnrs Limited Liability Com invested in 0.03% or 3,100 shares. Pensionfund Dsm Netherlands holds 0.71% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN) for 59,500 shares. Georgia-based Invesco Ltd has invested 0.22% in Texas Instruments Incorporated (NASDAQ:TXN). Oakworth has invested 0.04% in Texas Instruments Incorporated (NASDAQ:TXN). Great West Life Assurance Can reported 809,093 shares or 0.17% of all its holdings. Lmr Limited Liability Partnership has 0.07% invested in Texas Instruments Incorporated (NASDAQ:TXN) for 14,557 shares. Curbstone Financial Management invested 0.2% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Bokf Na owns 150,674 shares for 0.36% of their portfolio. Twin Cap Mngmt Inc holds 97,024 shares. Rowland And Invest Counsel Adv has invested 0% in Texas Instruments Incorporated (NASDAQ:TXN). Cantab Ptnrs Llp owns 13,498 shares or 0% of their US portfolio. Shamrock Asset Mgmt Lc reported 0% stake.

Among 36 analysts covering Texas Instruments (NASDAQ:TXN), 18 have Buy rating, 2 Sell and 16 Hold. Therefore 50% are positive. Texas Instruments had 90 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Outperform” rating by RBC Capital Markets on Thursday, October 22. On Thursday, October 22 the stock rating was maintained by UBS with “Buy”. The firm has “Neutral” rating given on Wednesday, January 25 by Mizuho. The rating was maintained by BMO Capital Markets with “Outperform” on Thursday, September 21. Cowen & Co maintained the stock with “Market Perform” rating in Thursday, October 27 report. As per Thursday, October 22, the company rating was downgraded by Robert W. Baird. B. Riley & Co maintained the stock with “Neutral” rating in Thursday, April 28 report. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Outperform” rating given on Tuesday, September 13 by Bernstein. Bernstein downgraded the stock to “Mkt Perform” rating in Friday, December 18 report. As per Monday, July 10, the company rating was maintained by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.